Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
About this episode
Experts discuss recent data and management strategies for non-muscle-invasive and muscle-invasive bladder cancer.
Dr Matthew D Galsky from The Tisch Cancer Institute in New York, New York, Dr Shilpa Gupta from Cleveland Clinic’s Taussig Cancer Institute in Ohio, Prof Andrea Necchi from IRCCS San Raffaele Hospital in Milan, Italy, and moderator Dr Terence Friedlander from the University of California, San Francisco discuss recent data surrounding the management of non-muscle-invasive and muscle-invasive bladder cancer, alongside their perspectives on clinical application and disease management. CME information and select publications here .
More episodes of Prostate Cancer Update
- Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
- Metastatic Bladder Cancer — Rapid Case Review Issue 4
- AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
- Metastatic Bladder Cancer — Rapid Case Review Issue 3
- Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review
- Metastatic Bladder Cancer — Rapid Case Review Issue 2
Explore listener stats, chart rankings, contacts and more on the Prostate Cancer Update podcast page.